COYA: Coya Therapeutics, Inc. Stock

by  •  • Comments Off on COYA: Coya Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 99.18
Enterprise Value ($M) 63.65
Book Value ($M) 33.37
Book Value / Share 2.00
Price / Book 2.97
NCAV ($M) 33.34
NCAV / Share 1.99
Price / NCAV 2.97

Profitability (mra)
Return on Invested Capital (ROIC) -0.51
Return on Assets (ROA) -0.46
Return on Equity (ROE) -0.53

Liquidity (mrq)
Quick Ratio 8.84
Current Ratio 8.84

Balance Sheet (mrq) ($M)
Current Assets 38.37
Assets 38.40
Liabilities 5.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.55
Operating Income -17.22
Net Income -14.88

Cash Flow Statement (mra) ($M)
Cash From Operations -10.29
Cash from Investing -0.03
Cash from Financing 16.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A DME Capital Management, LP 9.90
02-10 13G/A Hirschman Orin 8.00 14.56
11-12 13G/A Vanguard Group Inc 5.55 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-04-28 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Amendment No. 1 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANS
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-16 6,209 25,623 24.23
2025-05-15 6,995 33,121 21.12
2025-05-14 8,974 50,257 17.86
2025-05-13 9,620 105,706 9.10

(click for more detail)

Similar Companies
COCP – Cocrystal Pharma, Inc. COEP – Coeptis Therapeutics Holdings, Inc.
CORT – Corcept Therapeutics Incorporated CPRX – Catalyst Pharmaceuticals, Inc.
CRBP – Corbus Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io